|
CMV N495 peptide A nonapeptide consisting of amino acid residues 495-503 of the cytomegalovirus (CMV) internal matrix protein pp65 with immunostimulating activity. CMV N495 peptide may used as a control to gauge immunocompetence in individuals receiving cancer vaccines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
|
NCI Home |
Text-Only Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |